07:30 ETEndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosisprnewswire·Mar 23 at 06:30 AMIBB-0.86%PSTV-5.05%
Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climbrttnews·Nov 30, 2025 at 09:32 PMENTO0.00%BCAB-5.95%
Entero Therapeutics shares are trading lower. The company reported Q3 financial results.benzinga_article·Nov 20, 2025 at 10:53 AMENTO0.00%
Entero Therapeutics | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 19, 2025 at 04:15 PMENTO0.00%GRDX-8.70%
NASDAQ: ENTO's Grid AI Strikes Texas Hyperscale Deal as its $50M Industrial Software Platform Enters the AI RaceTip Ranks·Nov 19, 2025 at 08:00 AMENTO0.00%GRDX-8.70%
Entero Therapeutics’ Board Governance Structure UpdateTip Ranks·Nov 6, 2025 at 03:55 PMENTO0.00%GRDX-8.70%
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid | ENTO Stock NewsStockTitan·Nov 6, 2025 at 07:45 AMENTO0.00%GRDX-8.70%
